New cut-off values of cardiac markers for risk stratification of angina pectoris

International Journal of Cardiology

Volumn 99, Issue 3, 2005, Pages 429-435

  Jordanova, Nelly ^a   Gyöngyösi, Mariann ^a   Khorsand, Aliasghar ^a   Falkensammer, Christine ^a   Zorn, Gerlinde ^a   Wojta, Johann ^a   Anvari, Anahit ^a   Huber, Kurt ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiac markers; Risk stratification; TIMI risk score; Troponin; Unstable angina

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; FIBRINOGEN; MYOGLOBIN; TROPONIN I; TROPONIN T;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; RESPONSE TIME; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

EID: 14944343771     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.03.003     Document Type: Article

References (39)

1. Braunwald E. Unstable angina: a classification. Circulation. 80:1989;410-414
2. Braunwald E., Mark D.B., Johnes R.H., et al. Unstable angina: diagnosis and management. Clinical Practice Guideline, Number 10. Agency for Health Care Policy and Research Publication 94-0602. 1994;US Dept. of Health and Human Services, Rockville, MD
3. Calvin J.E., Klein L.W., Vandenberg B.J., et al. Risk stratification in unstable angina. Prospective validation of the Braunwald classification. JAMA. 273:1995;136-141
4. van Miltenburg-van Zijl A.J.M., Simoons M.L., Veerhoek R.J., Bossuyt P.M.M. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J. Am. Coll. Cardiol. 25:1995;1286-1292
5. Ahmed W.H., Bittl J.A., Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris and comparison with that in unstable angina. Am. J. Cardiol. 72:1993;544-550
6. Hamm C.W. Acute coronary syndromes. The diagnostic role of troponins. Thromb. Res. 103:2001;S63-S69
7. Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J., Wu A.H. Use of biochemical markers in acute coronary syndromes. Clin. Chem. Lab. Med. 37:1999;687-693
8. Apple F.S., Maturen A.J., Mullins R.E., Painter P.C., Pessin-Minsley M.S., Webster R.A. Multicenter clinical and analytical evaluation of the AxSyM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin. Chem. 45:1999;206-212
9. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N. Engl. J. Med. 327:1992;146-150
10. Antman E.M., Tanasijevic M.J., Tompson B., Schactman M. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med. 335:1996;1342-1349
11. Wu A., Apple F., Gibler W., Jesse R., Warshaw M., Valdes R. Nation Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin. Chem. 45:1999;1104-1121
12. Thygesen K. Do new biochemical markers of myocardial damage change the concept of unstable angina pectoris? Eur. Heart J. 19:1998;1749-1750
13. Antmann E.M., Cohen M., Bernink P.J.L.M., et al. The TIMI Risk Score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA. 284:2000;835-842
14. Antmann E.M., McCabe C.H., Gurfinkel E.P., et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial. Circulation. 100:1999;1593-1601
15. Cohen M., Demers C., Gurfinkel E., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N. Engl. J. Med. 337:1997;447-452
16. Metz C.E., Herman B.A., Roe C.A. Statistical comparison of two ROC curve estimates obtained from partially-paired datasets. Med. Decis. Mak. 18:1998;110-121
17. Morrow D.A., Antman E.M., Snapinn S.M., McCabe C.H., Theroux P., Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur. Heart J. 23:2002;223-229
18. Ottani F., Galvani M., Ferrini D., et al. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina. Am. Heart J. 137:1999;284-291
19. Jurlander B., Clemmensen P., Wagner G.S., Grande P. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin T, myoglobin and creatine kinase MB mass. Eur. Heart J. 21:2000;382-389
20. Wu A., Apple F., Gibler W., Jesse R., Warshaw M., Valdes R. Nation Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin. Chem. 45:1999;1104-1121
21. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K., Go A.S., Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J. Am. Coll. Cardiol. 38:2001;478-485
22. Heeschen C., et al. for the PRISM Study Investigators Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 354:1999;1757-1762
23. Hamm C.W., Goldmann B.U., Heeschen C., Kreymann G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N. Engl. J. Med. 337:1997;1648-1653
24. Lindahl B., Venge P., Wallentin L. The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers. Eur. Heart J. 19:1998;N51-N58
25. Solymoss B.C., Bourassa M.G., Wesolowska E., et al. The role of cardiac troponin T and other new biochemical markers in elevation and risk stratification of patients with acute chest pain syndromes. Clin. Cardiol. 20:1997;934-942
26. Morrow D.A., Cannon C.P., Rifai N., et al. TACTICS-TIMI 18 Investigators. Ability of minor elevation of troponins I and T to predict benefit from an early invasive strategy in patients with unstable anguna and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 286:2001;2405-2412
27. Morrow D.A., Rifai N., Tanasijevic M.J., Wybenga D.R., de Lemos J.A., Antman E.M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11B substudy. Clin. Chem. 46:2000;453-460
28. Jaffe A.S., Ravkilde J., Roberts R., et al. It's time for a change to a troponin standard. Circulation. 102:2000;1216-1220
29. Venge P., et al. on behalf of the FRISC II Study Group Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II Substudy). Am. J. Cardiol. 89:2002;1035-1041
30. Collinson P.O., Boa F.G., Gaze D.C. Measurement of cardiac troponins. Ann. Clin. Biochem. 38:2001;423-449
31. Wong G.C., et al. for the TACTICS-TIMI 18 Study Group Elevations in troponin T and I are associated with abnormal tissue level perfusion. A TACTICS-TIMI 18 Substudy. Circulation. 106:2002;202-207
32. Smith S.C., Ladenson J.H., Mason J.W., Jaffe A.S. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 95:1997;163-168
33. Missow E., Calzolari C., Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 96:1997;2953-2958
34. Lauer B., Niederau C., Kuhl U., et al. Cardiac troponin T in patients with clinically suspected myocarditis. J. Am. Coll. Cardiol. 30:1997;1354-1359
35. Apple F.S., Christenson R.H., Valdes R., et al. Simultaneous rapid measurement of whole blood myoglomin, creatine kinase MB, and cardiac troponin I by the Triage Cardiac Panel for detection of myocardial infarction. Clin. Chem. 45:1999;199-205
36. Newby L.K., Storrow A.B., Gibler W.B., et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin and troponin I (CHECKMATE) study. Circulation. 103:2001;1832-1837
37. Mair J., Morandelli D., Genser N., Lechleitner P., Dienstl F., Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponin I and T for acute myocardial infarction. Clin. Chem. 41:1995;1266-1272
38. Toss H., Lindahl B., Siegbahn A., Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation. 96:1997;4204-4210
39. Ford E.S., Giles W.H. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III. J. Clin. Epidemiol. 53:2000;95-102